Statement on Building a Tuberculosis Free World: The Lancet Commission on Tuberculosis
March 20, 2019 – Building a Tuberculosis Free World: The Lancet Commission on Tuberculosis, released today, outlines what is needed […]
News
TB Medicine Pretomanid Enters Regulatory Review Process in the United States
NEW YORK, NY (March 8, 2019)—TB Alliance’s new drug application (NDA) for the novel tuberculosis (TB) drug candidate pretomanid has
Compound Studied in TB to be Evaluated in the Treatment of Leishmaniasis
NEW YORK (February 5, 2019) – TB Alliance applauds the Wellcome Trust’s commitment of over £10 million to the Drugs
Increased Commitment to Neglected Disease R&D, but TB Landscape Remains Largely Unchanged
January 23, 2019 – The 2018 G-FINDER report shows that while funding for tuberculosis (TB) research and development (R&D) reached
Played Red Dead Redemption 2? Here’s what you should know about TB
Please note: this article discusses a major plot point of Red Dead Redemption 2 For players of Red Dead Redemption
Jan Lundberg Joins TB Alliance Board of Directors
NEW YORK (January 15, 2019)—TB Alliance, a not-for-profit organization dedicated to developing new drug regimens to fight tuberculosis (TB), has
Schrödinger and TB Alliance Announce Collaboration to Accelerate Tuberculosis Drug Discovery
NEW YORK – Dec. 11, 2018 – Schrödinger and TB Alliance today announced a three-year research collaboration to speed the
Global TB Research Funding Continues to Fall Short
December 4, 2018 – NEW YORK – Though global funding for tuberculosis (TB) research is beginning to move in the
TB Alliance Receives GHTC Partnership Award for Development of Child-Friendly TB Medicines
[November 28, 2018, WASHINGTON, D.C.] – TB Alliance and partners were honored today as the winner of the Global Health
Closing the TB Funding Gap
Project Syndicate Op-Ed by Willo Brock, SVP External Affairs, TB Alliance NEW YORK – In the 25 years since tuberculosis